NCT07524556 (WF-GAIT-FALL) is a clinical trial in Multiple Sclerosis, sponsored by Ibrahim Ahmad Elmongy.

Who is sponsoring NCT07524556?

NCT07524556 is sponsored by Ibrahim Ahmad Elmongy.

What condition does NCT07524556 study?

NCT07524556 studies Multiple Sclerosis.

Is NCT07524556 still recruiting?

NCT07524556 is currently not yet recruiting. Last updated 13 April 2026.

Last reviewed 2026-04-13 · How we verify

NCT07524556: WF-GAIT-FALL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Walking Fatigability,Saptiotemporal Gait Parameters and Falling in MS Patients

Not yet recruiting Last updated 13 April 2026

What this trial tests

trial in Multiple Sclerosis in 62 participants. Not yet recruiting.

Timeline

1 April 2026

Primary endpoint
1 July 2026

1 July 2026

Quick facts

Lead sponsor	Ibrahim Ahmad Elmongy
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	62
Start date	1 April 2026
Primary completion	1 July 2026
Estimated completion	1 July 2026
Sites	1 location across Egypt

Conditions studied

Multiple Sclerosis — all drugs for Multiple Sclerosis →

Sponsor

Ibrahim Ahmad Elmongy

Who can join

Adults 20 to 40, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This observational study aims to investigate the relationship between walking fatigability, changes in spatiotemporal gait parameters, and risk of falling in individuals with multiple sclerosis (MS). Participants will be divided into two groups: those with walking fatigability and those without. Each participant will undergo functional tests to detect deterioration in patiotemoral gait parameters and risk of falling . The results of this study will help understand how walking fatigability affects gait and fall risk in MS, providing insights for rehabilitation strategies.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07524556 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ibrahim Ahmad Elmongy
Last refreshed: 13 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07524556.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing